Drugs Made In America Acquisition Corp. Files S-1/A Amendment
Ticker: DMAAR · Form: S-1/A · Filed: Jan 6, 2025 · CIK: 2028614
| Field | Detail |
|---|---|
| Company | Drugs Made In America Acquisition Corp. (DMAAR) |
| Form Type | S-1/A |
| Filed Date | Jan 6, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: spac, registration, amendment
TL;DR
DMAA files S-1/A amendment, still working on their SPAC deal.
AI Summary
Drugs Made In America Acquisition Corp. filed an S-1/A amendment on January 6, 2025, for its registration statement. The company, incorporated in the Cayman Islands, is classified under 'BLANK CHECKS' with SIC code 6770. Its principal executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301.
Why It Matters
This filing indicates ongoing regulatory compliance and potential future public offerings or business developments for the blank check company.
Risk Assessment
Risk Level: medium — Blank check companies (SPACs) inherently carry higher risk due to their reliance on finding and merging with a target company.
Key Numbers
- 333-281170 — SEC File Number (Identifies the specific registration filing with the SEC.)
- 6770 — SIC Code (Classifies the company under 'BLANK CHECKS'.)
Key Players & Entities
- Drugs Made In America Acquisition Corp. (company) — Registrant
- January 6, 2025 (date) — Filing Date
- Cayman Islands (location) — Jurisdiction of Incorporation
- 6770 (sic_code) — Standard Industrial Classification
- Lynn Stockwell (person) — CEO and Executive Chair
- 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 (address) — Principal Executive Offices
- 333-281170 (registration_number) — SEC File Number
FAQ
What is the purpose of this S-1/A filing?
This is an amendment (Amendment No. 6) to the Form S-1 Registration Statement filed by Drugs Made In America Acquisition Corp.
When was this amendment filed?
The amendment was filed on January 6, 2025.
Where is Drugs Made In America Acquisition Corp. incorporated?
The company is incorporated in the Cayman Islands.
Who is the CEO of Drugs Made In America Acquisition Corp.?
Lynn Stockwell serves as the Chief Executive Officer and Executive Chair.
What is the company's business address?
The company's principal executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301.
Filing Stats: 1,833 words · 7 min read · ~6 pages · Grade level 15.3 · Accepted 2025-01-06 16:57:07
Filing Documents
- ea0209546-10.htm (S-1/A) — 138KB
- ea020954610ex23-1_drugs.htm (EX-23.1) — 2KB
- 0001213900-25-001208.txt ( ) — 142KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Amendment No. 6 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fort Lauderdale, State of Florida, on the 6 th day of January, 2025.   Drugs Made In America Acquisition Corp.     By:   /s/ Lynn Stockwell     Name:   Lynn Stockwell     Title:   Chief Executive Officer and Executive Chair Pursuant to the requirements of the Securities Act of 1933, as amended, this Amendment No. 6 to the Registration Statement has been signed below by the following persons in the capacities and on the dates indicated. Name   Position   Date /s/ Lynn Stockwell   Chief Executive Officer and Executive Chair   January 6, 2025 Lynn Stockwell   (principal executive officer)     /s/ Glenn Worman   Chief Financial Officer   January 6, 2025 Glenn Worman   (principal financial and accounting officer)     II-3